• Something wrong with this record ?

European Association for the Study of Diabetes : 45 Annual Meeting : Vienna, Austria, 29 September - 2 October 2009

Novo Nordisk

Published
Bagsværd : Novo Nordisk, 2009
Pagination
145 stran : ilustrace, tabulky ; 21 cm

Language English Country Denmark

Document type Congress, Abstracts, Collected Work

Persistent link   https://www.medvik.cz/link/MED00207693

A collection of abstracts of works presented at a conference that focused on diabetes research and on the treatment of type 2 diabetes with Victoza (liraglutide). Intended for professional public.

Book of abstracts

EASD 2009

Bibliography, etc.

Obsahuje rejstřík

Owner Details Services
NLK NLK Shelf no. Q 2486 [1]
Volume Location Shelf no. Status Order
000      
00000nam a2200000 i 4500
001      
MED00207693
003      
CZ-PrNML
005      
20210914080145.0
007      
ta
008      
210816s2009 dk d e 100 0|eng||
009      
BK
020    __
$q (Brožováno)
040    __
$a ABA008 $b cze $d ABA008 $e rda
041    0_
$a eng
044    __
$a dk
072    _7
$a 616 $x Patologie. Klinická medicína $2 Konspekt $9 14 $7 sk136316
110    2_
$a European Association for the Study of Diabetes. $b Meeting $n (45. : $d 2009 : $c Vídeň, Rakousko) $7 xx0264002
245    10
$a European Association for the Study of Diabetes : $b 45 Annual Meeting : Vienna, Austria, 29 September - 2 October 2009 / $c Novo Nordisk
246    13
$a Book of abstracts
246    18
$a EASD 2009
264    _1
$a Bagsværd : $b Novo Nordisk, $c 2009
300    __
$a 145 stran : $b ilustrace, tabulky ; $c 21 cm
336    __
$a text $b txt $2 rdacontent
337    __
$a bez média $b n $2 rdamedia
338    __
$a svazek $b nc $2 rdacarrier
504    __
$a Obsahuje rejstřík
520    __
$a A collection of abstracts of works presented at a conference that focused on diabetes research and on the treatment of type 2 diabetes with Victoza (liraglutide). Intended for professional public.
650    07
$a diabetologie $7 nlk20040151698 $2 mednas
650    07
$a farmacie a farmakologie $7 nlk20040147252 $2 mednas
650    07
$a diabetes mellitus 2. typu $x farmakoterapie $7 D003924 $2 czmesh
650    07
$a liraglutid $x terapeutické užití $7 D000069450 $2 czmesh
650    07
$a farmakoterapie $7 D004358 $2 czmesh
650    07
$a hodnocení léčiv $7 D004341 $2 czmesh
650    07
$a preklinické hodnocení léčiv $7 D004353 $2 czmesh
650    07
$a inzuliny $x terapeutické užití $7 D061385 $2 czmesh
655    _7
$a kongresy $7 D016423 $2 czmesh
655    _7
$a abstrakty $7 D020504 $2 czmesh
655    _7
$a sborníky $7 D020470 $2 czmesh
710    2_
$a Novo Nordisk (firma) $7 kn20010710263
910    __
$a ABA008 $b Q 2486 $y 6
990    __
$a 20210806142846 $b ABA008
991    __
$a 20210914080141 $b ABA008
999    __
$a ok $b medvik21 $g 1680333 $s 224406
BAS    __
$a 30
LZP    __
$b 120/5.8.2021
Back